
Cagrilintide
Price to be confirmedLong-acting amylin analogue · receptor research. Specific research findings are under review.
Also known as AM833
Metabolic research · vial
PEPTIQ catalogue
A Canada-only catalogue of research materials and supplies. All prices are in CAD; payment by Interac e-Transfer.
Molecules with different metabolic research topics. Some have human trial data; others have laboratory evidence or a pending review. Each listing identifies the evidence level. Trial medicines are not these catalogue products.

Long-acting amylin analogue · receptor research. Specific research findings are under review.
Also known as AM833
Metabolic research · vial

GLP-3 is a nickname for retatrutide. It targets three receptors, GLP-1, GIP and glucagon, and is being studied in clinical trials on metabolism and body weight.
Also known as Retatrutide
Metabolic research · vial

GLP-3 is a nickname for retatrutide. It targets three receptors, GLP-1, GIP and glucagon, and is being studied in clinical trials on metabolism and body weight.
Also known as Retatrutide
Metabolic research · vial

GLP-3 is a nickname for retatrutide. It targets three receptors, GLP-1, GIP and glucagon, and is being studied in clinical trials on metabolism and body weight.
Also known as Retatrutide
Metabolic research · vial

Targets GIP and GLP-1 receptors. Clinical trials in adults with type 2 diabetes measured blood-sugar control and body weight.
Also known as LY3298176
Metabolic research · vial

Targets GIP and GLP-1 receptors. Clinical trials in adults with type 2 diabetes measured blood-sugar control and body weight.
Also known as LY3298176
Metabolic research · vial

Targets GIP and GLP-1 receptors. Clinical trials in adults with type 2 diabetes measured blood-sugar control and body weight.
Also known as LY3298176
Metabolic research · vial